KJIM :: Korean Journal of Internal Medicine

Ovarian cancer extracellular vesicle biomarkers

Zeinab Jamali, Masoumeh Razipour, Mahsa Zargar, Hojat Ghasemnejad-Berenji, Seyed Mohammad Akrami

Composition analysis and mechanism of Guizhi Fuling capsule in anti-cisplatin-resistant ovarian cancer

Lei Dou, Yan Yan, Enting Lu, Fangmei Li, Dongli Tian, Lei Deng, Xue Zhang, Rongjin Zhang, Yin Li, Yi Zhang, Ye Sun

Translational Oncology.2025; 52: 102244. CrossRef

Investigation of in vitro Cytotoxic Activity of Arbutin on Human Ovarian Cancer Cell Line

Commagene Journal of Biology.2025; 9(1): 99. CrossRef

Advances in ovarian tumor stem cells and therapy

Cell Biochemistry and Biophysics.2024; 82(3): 1871. CrossRef

The Effects of Chemotherapy Education Reflecting Educational Needs on Self-Care Knowledge and Performance in Female Cancer Patients: A Non-Equivalent Control Group Pretest-Posttest Design

Asian Oncology Nursing.2024; 24(3): 103. CrossRef

Insights into high-grade serous carcinoma pathobiology using three-dimensional culture model systems

A combined network pharmacology and molecular biology approach to investigate the potential mechanisms of G-M6 on ovarian cancer

Meng Ding, Cuifang Dong, Yufeng Mao, Shuheng Liu, Yuqing Zhao, Xude Wang

A Comprehensive Analysis of Prognostic Indicators in Serous Ovarian Cancer Based on Leukocyte Migration and Immune Microenvironment

Junping Pan, Xiaochuan Chen, Lin Yang, Yanwen Song, Jing Liu, Li Li, Yibin Lin, Lina Tang, Sufang Qiu, Qin Xu

Frontiers in Bioscience-Landmark.2023;[Epub] CrossRef

Expression of Enhancer-Binding Protein CEBPA mRNA and Protein in Ovarian Cancer and Its Relationship With Pathobiological Characteristics

Shufang Mi, Limei Zhang, Mo Li, Zhiting Dong, Chenchen Tian, Minwen Fu

CTCFL regulates the PI3K-Akt pathway and it is a target for personalized ovarian cancer therapy

Marisol Salgado-Albarrán, Julian Späth, Rodrigo González-Barrios, Jan Baumbach, Ernesto Soto-Reyes

npj Systems Biology and Applications.2022;[Epub] CrossRef

The Effect of Bone Marrow Mesenchymal Stem Cells-Exosomes (BMSC-EXO) on Tumor Angiogenesis and Its Mechanism in Ovarian Cancer Microenvironment

Journal of Biomaterials and Tissue Engineering.2022; 12(6): 1087. CrossRef

Plasma-activated medium inhibits cancer stem cell-like properties and exhibits a synergistic effect in combination with cisplatin in ovarian cancer

Young Joo Lee, Sung Wook Kim, Min Hyung Jung, Young Sun Kim, Kyung Sook Kim, Dong Soo Suh, Ki Hyung Kim, Eun Ha Choi, Jongmin Kim, Byung Su Kwon

Free Radical Biology and Medicine.2022; 182: 276. CrossRef

The impact of the modified frailty index on clinical outcomes for patients with stage IV non-small cell lung cancer receiving chemotherapy

Shivani Mathur, Laura Prince, Oliver Bucher, Lin Xue, Shantanu Banerji, David E. Dawe

Journal of Geriatric Oncology.2022; 13(5): 654. CrossRef

Ncald as a Potential Predictive Biomarker for the Efficacy of Platinum-Based Chemotherapy in Ovarian Cancer

Sarah M Konrad, Kristina Schwamborn, Achim Krüger, Katja Honert, Manfred Schmitt, Daniela Hellmann, Barbara Schmalfeldt, Alfons Meindl, Marion Kiechle, Anne S Quante, Christine Brambs, Sabine Grill, Juliane Ramser

Biomarkers in Medicine.2022; 16(14): 1029. CrossRef

miR-362-3p acts as a tumor suppressor by targeting SERBP1 in ovarian cancer

G Protein-Coupled Estrogen Receptor Correlates With Dkk2 Expression and Has Prognostic Impact in Ovarian Cancer Patients

Patricia Fraungruber, Till Kaltofen, Sabine Heublein, Christina Kuhn, Doris Mayr, Alexander Burges, Sven Mahner, Philipp Rathert, Udo Jeschke, Fabian Trillsch

LncRNA ARAP1-AS1 aggravates the malignant phenotypes of ovarian cancer cells through sponging miR-4735-3p to enhance PLAGL2 expression

Cuiping Li, Bing Dong, Xiaomeng Xu, Yuewen Li, Yan Wang, Xingmei Li

Effect of silencing C-erbB-2 on esophageal carcinoma cell biological behaviors by inhibiting IGF-1 pathway activation

Zhigao Niu, Wenping Zhang, Jialun Shi, Xiangdong Li, Hanlei Wu

Journal of Cardiothoracic Surgery.2021;[Epub] CrossRef

Targeting enhancer reprogramming to mitigate MEK inhibitor resistance in preclinical models of advanced ovarian cancer

Shini Liu, Qiong Zou, Jie-Ping Chen, Xiaosai Yao, Peiyong Guan, Weiting Liang, Peng Deng, Xiaowei Lai, Jiaxin Yin, Jinghong Chen, Rui Chen, Zhaoliang Yu, Rong Xiao, Yichen Sun, Jing Han Hong, Hui Liu, Huaiwu Lu, Jianfeng Chen, Jin-Xin Bei, Joanna Koh, Jas

Journal of Clinical Investigation.2021;[Epub] CrossRef

Immunostimulatory effects of targeted thorium-227 conjugates as single agent and in combination with anti-PD-L1 therapy

Pascale Lejeune, Véronique Cruciani, Axel Berg-Larsen, Andreas Schlicker, Anne Mobergslien, Lisa Bartnitzky, Sandra Berndt, Sabine Zitzmann-Kolbe, Claudia Kamfenkel, Stefan Stargard, Stefanie Hammer, Jennifer S Jørgensen, Malene Jackerott, Carsten H Niels

Journal for ImmunoTherapy of Cancer.2021; 9(10): e002387. CrossRef

Chitosan is a potential inhibitor of ovarian cancer: Molecular aspects

Maryam Chamani, Parisa Maleki Dana, Shahla Chaichian, Bahram Moazzami, Zatollah Asemi

Sensitive competitive label-free electrochemical immunosensor for primal detection of ovarian cancer

Preclinical immunotherapy with Cytokine-Induced Killer lymphocytes against epithelial ovarian cancer

S. Capellero, J. Erriquez, C. Melano, G. Mesiano, S. Genta, A. Pisacane, G. Mittica, E. Ghisoni, M. Olivero, M. F. Di Renzo, M. Aglietta, D. Sangiolo, G. Valabrega

Role of lncRNAHCP5/microRNA-525–5p/PRC1 crosstalk in the malignant behaviors of ovarian cancer cells

Experimental Cell Research.2020; 394(1): 112129. CrossRef

Immune profiling reveals prognostic genes in high-grade serous ovarian cancer

Yong Wu, Lingfang Xia, Ping Zhao, Yu Deng, Qinhao Guo, Jun Zhu, Xiaojun Chen, Xingzhu Ju, Xiaohua Wu

A real-world study on characteristics, treatments and outcomes in US patients with advanced stage ovarian cancer

Daniel C. Beachler, Francois-Xavier Lamy, Leo Russo, Devon H. Taylor, Jade Dinh, Ruihua Yin, Aziza Jamal-Allial, Samuel Dychter, Stephan Lanes, Patrice Verpillat

Pharmacological Inhibition of BAD Ser99 Phosphorylation Enhances the Efficacy of Cisplatin in Ovarian Cancer by Inhibition of Cancer Stem Cell-like Behavior

Yanxin Wang, Yi-Shiou Chiou, Qing-Yun Chong, Mengyi Zhang, Kanchuragoppal S. Rangappa, Lan Ma, Tao Zhu, Alan Prem Kumar, Ruby Yun-Ju Huang, Vijay Pandey, Basappa, Peter E. Lobie

ACS Pharmacology & Translational Science.2020; 3(6): 1083. CrossRef

Emerging role of immune checkpoint inhibitors in the treatment of ovarian cancer

Domenica Lorusso, Valentina Ceni, Margherita Muratore, Vanda Salutari, Camilla Nero, Antonella Pietragalla, Francesca Ciccarone, Vittoria Carbone, Gennaro Daniele, Giovanni Scambia

Expert Opinion on Emerging Drugs.2020; 25(4): 445. CrossRef

Epithelial-mesenchymal interconversions in ovarian cancer: The levels and functions of E-cadherin in intraabdominal dissemination

Ricardo Roque, Filipa Costa Sousa, Margarida Figueiredo-Dias

SRT2183 impairs ovarian cancer by facilitating autophagy

Tingting Sun, Yanfen Hu, Weipeng He, Yuru Shang, Xiaohong Yang, Liyun Gong, Xianbin Zhang, Peng Gong, Guofen Yang

Monoclonal antibody against human Tim‐3 enhances antiviral immune response

Ge Li, Chunmei Hou, Shuaijie Dou, Jiacheng Zhang, Yanling Zhang, Yiqiong Liu, Zhiding Wang, He Xiao, Renxi Wang, Guojiang Chen, Yan Li, Jiannan Feng, Beifen Shen, Gencheng Han

Scandinavian Journal of Immunology.2019;[Epub] CrossRef

Matrine inhibits the development and progression of ovarian cancer by repressing cancer associated phosphorylation signaling pathways

Xi Zhang, Guoqing Hou, Andong Liu, Hui Xu, Yang Guan, Yaosong Wu, Jie Deng, Xuan Cao

Long Noncoding RNA LINC01133 Confers Tumor-Suppressive Functions in Ovarian Cancer by Regulating Leucine-Rich Repeat Kinase 2 as an miR-205 Sponge

The American Journal of Pathology.2019; 189(11): 2323. CrossRef

Role of lncRNA‑ATB in ovarian cancer and its mechanisms of action

Donglan Yuan, Xiaofang Zhang, Yinling Zhao, Hua Qian, Hezhu Wang, Cuiqin He, Xia Liu, Ting Guo, Mei Lin, Hong Yu, Jun Ye

Experimental and Therapeutic Medicine.2019;[Epub] CrossRef

Chemotherapy-Induced Distal Enhancers Drive Transcriptional Programs to Maintain the Chemoresistant State in Ovarian Cancer

Stephen Shang, Jiekun Yang, Amir A. Jazaeri, Alexander James Duval, Turan Tufan, Natasha Lopes Fischer, Mouadh Benamar, Fadila Guessous, Inyoung Lee, Robert M. Campbell, Philip J. Ebert, Tarek Abbas, Charles N. Landen, Analisa Difeo, Peter C. Scacheri, Ma

WITHDRAWN: Addition of targeted agents to chemotherapy for persistent or recurrent ovarian cancer: a meta-analysis of randomized controlled trials

Xiao Li, Yuchan Mao, Qiwen Wu, Yuanyuan Liu, Qianqian Wu, Binghuan Wen

Critical Reviews in Oncology/Hematology.2018;[Epub] CrossRef